Interferon-γ-induced ICAM-1 and CD40 expression, complete lack of HLA- DR and CD80 (B7.1), and inconsistent HLA-ABC expression in basal cell carcinoma: A possible role for interleukin-10?

Journal of Pathology

Volumn 187, Issue 3, 1999, Pages 351-357

  Kooy, Angela J W ^b   Prens, Errol P ^b   Van Heuklelum, Alexander ^b   Vuzevski, Voijslav D ^b   Van Joost, Theodoor ^b   Tank, Bhupendra ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b NONE

Author keywords

B7.1; Basal cell carcinoma; CD40; Ex vivo culture; ICAM 1; IFN ; IL 10; MHC antigens

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, NEOPLASM; CARCINOMA, BASAL CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-DR ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-10; MALE; MIDDLE AGED; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0032896834     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199902)187:3<351::AID-PATH227>3.0.CO;2-6     Document Type: Article

References (29)

1. + (B) cells. J Invest Dermatol 1988; 90: 289-292.
2. Markey AC, Churchill LJ, Allen MH, MacDonald DM. Activation and inducer subset phenotype of the lymphocytic infiltrate around epidermally derived tumours. J Am Acad Dermatol 1990; 23: 214-222.
3. Vá;nky F, Wang P, Patarroyo M, Klein E. Expression of the adhesion molecule ICAM-1 and major histocompatibility complex I antigens on human tumour cells is required for their interaction with autologous lymphocytes in vitro. Cancer Immunol Immunother 1990; 31: 19-27.
4. Vánky F, Hising C, Sjöwall K, et al. Immunogenicity and immunosensitivity of ex vivo human carcinomas: interferon gamma and tumour necrosis factor alpha treatment of tumour cells potentiates their interaction with autologous blood lymphocytes. Cancer Immunol Immunother 1995; 41: 217-226.
5. Cavallo F, Martin-Fontecha A, Bellone M, et al. Co-expression of B7-1 and ICAM-1 on tumours is required for rejection and the establishment of a memory response. Eur J Immuno 1995; 25: 1154-1162.
6. Denfeld RW, Hollenbaugh D, Fehrenbach A, et al. CD40 is functionally expressed on human keratinocytes. Eur J Immunol 1996; 26: 2329-2334.
7. van Gool AW, Vandenberghe P, de Boer M, Ceuppens JL. CD80, CDS6 and CD40 provide accessory signals in a multiple-step T-cell activation model. Immunol Rev 1996; 153: 47-83.
8. Griffiths CEM, Voorhees JJ, Nickloff BJ. Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumour necrosis factor. J Am Acad Dermatol 1989; 20: 617-629.
9. Buchsbaum ME, Kupper TS, Murphy GF. Differential induction of intercellular adhesion molecule-1 in human skin by recombinant cytokines. J Cutan Pathol 1993: 20: 21-27.
10. Li J, Yang Y, Inoue H, Mori M, Akiyoshi T. The expression of costimulatory molecules CD80 and CD86 in human carcinoma cell lines: its regulation by interferon gamma and interleukin-10. Cancer Immunol Immunother 1996; 43: 213-219.
11. Kohchiyama A, Oka D, Ueki H. Expression of human lymphocyte antigen (HLA)-DR on tumour cells in basal cell carcinoma. J Am Acad Dermatol 1987; 16: 833-838.
12. Habets JMW, Tank B, Vuzevski VD, Stolz E, van Joost T. An absence of human leukocyte antigen-DR and a decreased expression of β2-microglobulin on tumour cells of basal cell carcinoma: no influence on the peritumoral immune infiltrate. J Am Acad Dermatol 1989; 20: 47-52.
13. Cabrera T, Garrido V, Concha A, et al. HLA molecules in basal cell carcinoma of the skin. Immunobiology 1992; 185: 440-452.
14. Cabrera T, Ruiz-Cabello F, Garrido F. Biological implications of HLA-DR expression in tumours. Scand J Immunol 1995; 41: 398-406.
15. Barker JNWN, Allen MH, MacDonald DM. Distribution of intercellular-adhesion molecule-1 (ICAM-1) and lymphocyte-function-associated antigen-1 (ILFA-1) in epidermal tumors. Clin Exp Dermatol 1990; 15: 331-334.
16. Kikuchi A, Sakuraoka K, Shimizu H, Nishikawa T. Immunohistochemical evaluation of epidermis overlying basal cell carcinomas. Br J Dermatol 1993; 128: 644-649.
17. Wrone-Smith T, Johnson T, Nelson B, et al. Discordant expression of Bcl-x and Bcl-2 by keratinocyte in vitro and in psoriatic keratinocytes in vivo. Am J Pathol 1995; 146: 1079-1088.
18. Viac J, Schmitt D, Claudy A. CD40 expression in epidermal tumors. Anticancer Res 1997; 17: 569-572.
19. Yue FY, Dummer R, Geertsen R, et al. Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules. Int J Cancer 1997; 71: 630-637.
20. Kooy AJW, Tank H, Vuzevski VD, Van Joost T, Prens EP. Expression of interferon-gamma receptors and interferon-gamma-induced up-regulation of intercellular adhesion molecule-1 in basal cell carcinoma: decreased expression of IFN-γR and shedding of ICAM-1 as a means to escape immune surveillance. J Pathol 1998; 184: 169-176.
21. Kooy AJW, Tank B, Vuzevski VD, Van Joost T. Expression of cytokeratin 8 and low molecular weight cytokeratins in human basal cell carcinoma. Anticancer Res 1995; 15: 241-248.
22. Gaspari AA, Sempowski GD, Chess P, Gish J, Phipps RP. Cultured human keratinocyles express functional CD40 that mediates protein tyrosine kinase-dependent transmembrane signals and costimulates resting T-lymphocyte proliferation (Abstract). J Invest Dermatol 1996; 106: 924.
23. Nishio M, Spielman J, Lee RK, Nelson DL, Podack ER. CD80 (B7.1) and CD54 (intracellular adhesion molecule-1) induce target cell susceptibility to promiscuous cytotoxic T cell lysis. J Immunol 1996; 157: 4347-4353.
24. Döhring C, Angman L, Spagnoli G, Lanzavecchia A. T-helper- and accessory-cell-independent cytotoxic responses to human tumour cells transfected with a B7 retroviral vector. Int J Cancer 1994; 57: 754-759.
25. Krüger-Krasagakes S, Krasagakis K, Garbe C, et al. Expression of interleukin 10 in human melanoma. Br J Cancer 1994; 70: 11821-1185.
26. Grewe M, Gyufko K, Krutmann J. Interleukin-10 production by cultured human keratinocytes: regulation by ultraviolet B and ultraviolet Al radiation. J Invest Dermatol 1995; 104: 3-6.
27. Teunissen MBM, Koomen CW, Jansen J, et al. In contrast to their murine counterparts, normal human keratinocytes and human epidermoid cell lines A431 and HaCaT fail to express IL-10 mRNA and protein. Clin Exp Immunol 1997; 107: 213-223.
28. Kim J, Modlin RL, Moy RL, et al. IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J Immunol 1995; 155: 2240-2247.
29. Yamamura M, Modlin RL, Ohmen JD, Moy RL. Local expression of anti-inflammatory cytokines in cancer. J Clin Invest 1993; 91: 1005-1010.